Comparative analysis of cardiometabolic multimorbidity predictors in China and the USA: A machine learning approach

Jingjing Zhu1, Zumin Shi2, Zongyuan Ge3

  • 1School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Insights

Developing a bidirectional machine learning model for cardiometabolic multimorbidity (CMM) screening identified key risk factors. Tailored screening strategies for China and the USA improve early detection of cardiovascular disease (CVD) and metabolic diseases (MD).

Area of Science:

  • Public Health
  • Computational Biology
  • Epidemiology

Background:

  • Cardiometabolic multimorbidity (CMM), the co-occurrence of cardiovascular disease (CVD) and metabolic diseases (MD), poses a significant global health challenge.
  • Current screening tools for CMM are insufficient and lack applicability across different nations, particularly between the USA and China.
  • There is a critical need for advanced, cross-nationally applicable screening methods to identify individuals at risk for CMM.

Purpose of the Study:

  • To develop and validate a bidirectional machine learning (ML) model for predicting cardiometabolic multimorbidity (CMM) risk.
  • To identify distinct and shared risk factors for CMM in China and the USA.
  • To enable precision screening and inform region-specific public health interventions for CMM.

Main Methods:

  • Utilized data from the Chinese Health and Retirement Longitudinal Survey (CHARLS) and the US Health and Retirement Study (HRS).
  • Developed and compared bidirectional ML models, including logistic regression (LR), Gaussian Naive Bayes (GNB), and extreme gradient boosting (XGBoost).
  • Evaluated model performance using Area Under the Curve (AUC) and performed cross-national validation with SHAP analysis for predictor identification.

Main Results:

  • Logistic regression models demonstrated strong performance in predicting cardiovascular disease (CVD) (AUC = 0.70 in both countries).
  • Predictive accuracy for metabolic diseases (MD) varied, with LR (AUC = 0.71) excelling in China and GNB (AUC = 0.65) in the USA.
  • Core predictors included disease counts and moderate physical activity, with unique regional predictors identified, such as grip strength in China and pulse/emotional problems in the USA.

Conclusions:

  • A validated, bidirectional ML model offers a promising tool for precision CMM screening across different countries.
  • Region-specific screening strategies are recommended, emphasizing grip strength and balance for China and pulse monitoring and psychological interventions for the USA.
  • This approach facilitates targeted public health interventions to mitigate the burden of cardiometabolic multimorbidity.
Abstract